Press Release

This user hasn't shared any profile information

On Friday, the Food and Drug Administration (FDA) approved new warnings about an increased risk of blood clots and of death with the 10 mg twice daily dose of Xeljanz, Xeljanz XR (tofacitinib), which is...

The U.S. Food and Drug Administration (FDA), along with the Centers for Disease Control and Prevention (CDC), and state and local partners, are investigating a multistate outbreak of Cyclospora illnesses...

There is a critical need for O Positive blood donors Due to increased use by area hospitals OneBlood, the local blood center, is urging people with O Positive blood to please donate as soon as possible. 37%...

A Middle East respiratory syndrome coronavirus (MERS CoV) vaccine candidate was shown to be safe, well-tolerated, and induced a robust immune response in a Phase 1 first-in-human clinical trial. Initial...

Local merchants are sharing their power to save lives by hosting ‘Tax Free Day Back To School’ blood drives.  Donors can give blood and enjoy a $10 Gift Card, plus receive a wellness checkup of blood...

Genomic surveillance has revealed that malaria resistance to two first-line antimalarial drugs has spread rapidly from Cambodia to neighbouring countries in Southeast Asia. Researchers from the Wellcome...

Many common medications, including antibiotics, drugs used for high blood pressure and to lower cholesterol, even over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin, ibuprofen,...

On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy,...

Most people have probably been stung by a bee and while it can be painful, it’s especially dangerous for those at risk of suffering a life threatening allergic reaction.  Researchers have successfully...

Cell Vault, the world’s first t-cell bank, announced today it has raised $1 million in an initial round of funding. The early investment in the company that offers t-cell banking for healthy individuals...